Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil

Leukemia

Volumn 11, Issue 5, 1997, Pages 743-746

  Sandlund, J T ^a,c   Fonseca, T ^b   Leimig, T ^b   Verissimo, L ^b   Ribeiro, R ^a   Lira, V ^b   Berard, C W ^a   Sixbey, J ^a   Crist, W M ^a   Mao, L ^a   Chen, G ^a   Pui, C H ^a   Heim, M ^a   Pedrosa, F ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HOSPITAL BARÃO DE LUCENA   (Brazil)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Brazil; Burkitt lymphoma; Epstein Barr virus

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ARTICLE; BRAZIL; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; JAW TUMOR; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 16944365444     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400609     Document Type: Article

References (15)

1. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
2. Murphy SB, Fairclough DL, Hutchison RE, Berard WC. Non-Hodgkin Iymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989; 7: 186-193.
3. Robison LL. General principles of the epidemiology of childhood cancer. In: Pizzo PA, Poplack DC (eds). Principles and Practice of Pediatric Oncology, 2nd edn. JB Lippincott: Philadelphia, 1993, pp 3-10.
4. Magrath IT. Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DC (eds). Principles and Practice of Pediatric Oncology, 2nd edn. JB Lippincott: Philadelphia, 1993, pp537-575.
5. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol 1980; 7: 332-339.
6. Can Y-J, Shirley P, Zeng Y, Sixbey JW. Human oropharyngeal lesions with a defective Epstein-Barr virus that disrupts viral Iatency. I Infect Dis 1993; 168: 1349-1355.
7. Wollner N, Exelby PR, Lieberman PH. Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol. Cancer 1979; 44: 1990-1999.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep 1996; 50: 163-170.
10. Pellici PC, Knowles DM, Magrath IT, Dalla-Favera R. Chromosomal breakpoints and structural alteration of the c-myc locus differ in endemic and sporadic forms of Burkitt's lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984-2988.
11. Shiramizu B, Barriga F, Neequayé-J, Jafri A, Dalla-Favera R, Neri A, Gutierrez MI, Levine P, Magrath IT. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516-1526.
12. de Carvalho ARL. Malignant lymphomas in Northeastern Brazil, J Natl Cancer Inst 1973; 50: 1645-1650.
13. Anderson JR, Jenkin RD, Wilson JF et al. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood nonHodgkin's lymphoma: a report of CG-551 from the Children's Cancer Group. J Clin Oncol 1993; 11: 1024-1032.
14. Gutierrez MI, Bhatia K, Barriga F, Diez B, Muriel SC, de Andreas ML, Epelman S, Risueño C, Magrath IT. Molecular epidemiology of Burkitt's lymphoma from South America: differences in break-point location and Epstein-Barr virus association from tumors in other world regions. Blood 1992; 79: 3261-3266.
15. Singh V, Srinivas SK, Sixbey JW. Detection of defection (Wzhet) and integrated Epstein-Barr virus DNA in sporadic (EBNA-negative) Burkitt's lymphomas. Presented at the Cold Spring Harbor Conference on Cancer Cells, 1994.